ArticleCureus2025
Severe Neutropenia and Vitamin B12 Deficiency in a Patient With Recreational Nitrous Oxide Use and History of Polysubstance Use: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nitrous Oxide as a Recreational Drug of Abuse: Multi-Omics Insights into MAPK/ERK/CREB-Mediated Neurotoxicity and Energy Metabolism Collapse.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nitrous oxide, commonly known as "laughing gas," has been widely used as a medical and dental sedative for centuries. Despite its recognized therapeutic applications, there has been a concerning rise in its recreational use, particularly among young adults. This trend has led to an increase in associated toxicities, including neurological, hematological, and psychiatric complications. This is a case report of a young adult presenting with neurological and hematological symptoms following chronic recreational nitrous oxide use. The patient exhibited diffuse abdominal pain, vomiting, nausea, confusion, and radicular pain in her upper extremities upon initial exam, which prompted an extensive diagnostic evaluation. These findings evolved during her hospital course, including the development of depressive symptoms, insomnia, and ataxia. Laboratory findings revealed evidence of severe neutropenia, pancytopenia, and vitamin B12 deficiency, supporting a diagnosis of nitrous oxide-induced neurotoxicity. Management included cessation of nitrous oxide exposure, vitamin B12 supplementation, psychiatric intervention, and supportive therapy, leading to gradual symptom improvement, which will hopefully continue in the outpatient setting. This case highlights the growing public health concern surrounding nitrous oxide abuse. Its recreational use can result in severe and potentially irreversible neurological impairment, often linked to its association with vitamin B12 deficiency. Increased awareness among healthcare providers is crucial for early recognition and intervention. Additionally, preventive measures, including public education and regulatory policies, may help curb the rising trend of nitrous oxide abuse. It is an emerging public health issue with significant consequences, and this case highlights the importance of early diagnosis and treatment, as well as the need for increased awareness to mitigate long-term complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.